Lung

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - PDF Version

Dingemans AC, Früh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, Lantuejoul S, Peters S, Reguart N, Rudin CM, De Ruysscher D, Van Schil PE, Vansteenkiste J, Reck M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.

Ann Oncol. 2021 Apr 9:S0923-7534(21)01113-3. doi: 10.1016/j.annonc.2021.03.207.

This publication does not have an abstract.

It is a timely update of new data in the field of small cell lung cancer, with consequences for clinical practice, also applies to radiation onclologists.

Highlights

• This ESMO Clinical Practice Guideline provides key recommendations for managing small-cell lung cancer (SCLC).
• It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
• Treatment algorithms for locoregional, advanced/metastatic and recurrent SCLC are provided.
• All recommendations were compiled by a multidisciplinary group of experts.
• Recommendations are based on available scientific data and the authors' collective expert opinion.